ERAS Erasca Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ERAS

Price (delayed)

$2.14

Market cap

$324.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.83

Enterprise value

$286.57M

Highlights
Erasca's EPS has surged by 58% YoY and by 52% QoQ
The company's net income rose by 49% YoY and by 46% QoQ
The equity has declined by 23% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ERAS
Market
Shares outstanding
151.49M
Market cap
$324.2M
Enterprise value
$286.57M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.02
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$125.04M
EBITDA
-$121.31M
Free cash flow
-$102.99M
Per share
EPS
-$0.83
Free cash flow per share
-$0.69
Book value per share
$2.1
Revenue per share
$0
TBVPS
$2.63
Balance sheet
Total assets
$395.3M
Total liabilities
$78.61M
Debt
$55.86M
Equity
$316.69M
Working capital
$294.52M
Liquidity
Debt to equity
0.18
Current ratio
12.26
Quick ratio
11.96
Net debt/EBITDA
0.31
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-29%
Return on equity
-35.6%
Return on invested capital
-40.7%
Return on capital employed
-33.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ERAS stock price

How has the Erasca stock price performed over time
Intraday
-0.47%
1 week
13.23%
1 month
-1.38%
1 year
-23.57%
YTD
0.47%
QTD
3.88%

Financial performance

How have Erasca's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$141.53M
Net income
-$125.04M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 49% YoY and by 46% QoQ
The company's operating income rose by 43% YoY and by 42% QoQ

Growth

What is Erasca's growth rate over time

Valuation

What is Erasca stock price valuation
P/E
N/A
P/B
1.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Erasca's EPS has surged by 58% YoY and by 52% QoQ
The equity has declined by 23% year-on-year and by 7% since the previous quarter
The P/B is 7% less than the last 4 quarters average of 1.1

Efficiency

How efficient is Erasca business performance
ERAS's return on invested capital has surged by 67% year-on-year and by 50% since the previous quarter
ERAS's ROA is up by 44% year-on-year and by 42% since the previous quarter
Erasca's return on equity has increased by 42% QoQ and by 41% YoY

Dividends

What is ERAS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ERAS.

Financial health

How did Erasca financials performed over time
The current ratio has increased by 34% YoY and by 7% QoQ
ERAS's quick ratio is up by 33% YoY and by 8% QoQ
The debt is 82% smaller than the equity
The debt to equity has increased by 38% YoY and by 6% from the previous quarter
The equity has declined by 23% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.